Candida sp in the oral cavity with and without lesions: maximal inhibitory dilution of Propolis and Periogard
Autor(a) principal: | |
---|---|
Data de Publicação: | 1999 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Revista de Microbiologia |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0001-37141999000400008 |
Resumo: | Fifty individuals of both sexes aged on average 45.2 years were evaluated at the Semiology Clinic of FORP-USP in order to isolate and identify yeasts from the oral cavity, with and without lesions, and to determine the maximal inhibitory dilution (MID) of the commercial products Propolis (Apis-Flora) and Periogard (Colgate) against the strains isolated. Yeasts of the genus Candida were detected in the saliva of 9/19 (47.4%) individuals with a clinically healthy mouth, 18/22 (81.8%) of individuals with oral lesions, and in 4/9 (44.4%) of patients with deviation from normality, and were detected in 19/22 (86.4%) of the lesions. In the group with oral candidiasis, we isolated in tongue and lesion, respectively for each specie: C.tropicalis (8% and 10.7%), C.glabrata (4% and 3.6%) and C.parapsilosis (2% and 3.6%), in addition to C.albicans (71.4% and 67.8%) as the only species and the prevalent. The total cfu counts/ml saliva showed a higher mean value in the group with oral candidiasis (171.5% x 10(3)) than in the control group (72.6 x 10(3)) or the group with abnormalities (8.3 x 10(3)). Most of the test strains 67/70 (95.71%) were sensitive to the antiseptics, with Propolis presenting a MID of 1:20 for 54/70/77.1%), and Periogard a MID of 1:160 for 42/70 (60%) strains from healthy sites, results similar to those obtained with strains from oral lesions. Different results were mainly observed among different species. The results indicate the possibility of using the antiseptics Propolis and Periogard (chlorhexidine) for the prevention and treatment of oral candidiasis. |
id |
SBM-2_fc9eb8dc3de30c0d96c0b2e80cc3179d |
---|---|
oai_identifier_str |
oai:scielo:S0001-37141999000400008 |
network_acronym_str |
SBM-2 |
network_name_str |
Revista de Microbiologia |
repository_id_str |
|
spelling |
Candida sp in the oral cavity with and without lesions: maximal inhibitory dilution of Propolis and PeriogardOral candidiasisPropolischlorhexidineyeastsFifty individuals of both sexes aged on average 45.2 years were evaluated at the Semiology Clinic of FORP-USP in order to isolate and identify yeasts from the oral cavity, with and without lesions, and to determine the maximal inhibitory dilution (MID) of the commercial products Propolis (Apis-Flora) and Periogard (Colgate) against the strains isolated. Yeasts of the genus Candida were detected in the saliva of 9/19 (47.4%) individuals with a clinically healthy mouth, 18/22 (81.8%) of individuals with oral lesions, and in 4/9 (44.4%) of patients with deviation from normality, and were detected in 19/22 (86.4%) of the lesions. In the group with oral candidiasis, we isolated in tongue and lesion, respectively for each specie: C.tropicalis (8% and 10.7%), C.glabrata (4% and 3.6%) and C.parapsilosis (2% and 3.6%), in addition to C.albicans (71.4% and 67.8%) as the only species and the prevalent. The total cfu counts/ml saliva showed a higher mean value in the group with oral candidiasis (171.5% x 10(3)) than in the control group (72.6 x 10(3)) or the group with abnormalities (8.3 x 10(3)). Most of the test strains 67/70 (95.71%) were sensitive to the antiseptics, with Propolis presenting a MID of 1:20 for 54/70/77.1%), and Periogard a MID of 1:160 for 42/70 (60%) strains from healthy sites, results similar to those obtained with strains from oral lesions. Different results were mainly observed among different species. The results indicate the possibility of using the antiseptics Propolis and Periogard (chlorhexidine) for the prevention and treatment of oral candidiasis.Sociedade Brasileira de Microbiologia1999-12-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0001-37141999000400008Revista de Microbiologia v.30 n.4 1999reponame:Revista de Microbiologiainstname:Sociedade Brasileira de Microbiologia (SBM)instacron:SBM10.1590/S0001-37141999000400008info:eu-repo/semantics/openAccessAzevedo,Rosa Vitória PalaminKomesu,Marilena ChinalliCandido,Regina CeliaSalvetti,CristianeRezende,Fausto Hanaoka Caetanoeng2000-04-19T00:00:00Zoai:scielo:S0001-37141999000400008Revistahttps://www.scielo.br/j/rm/ONGhttps://old.scielo.br/oai/scielo-oai.phpbjm@sbmicrobiologia.org.br||revmicro@icb.usp.br0001-37140001-3714opendoar:2000-04-19T00:00Revista de Microbiologia - Sociedade Brasileira de Microbiologia (SBM)false |
dc.title.none.fl_str_mv |
Candida sp in the oral cavity with and without lesions: maximal inhibitory dilution of Propolis and Periogard |
title |
Candida sp in the oral cavity with and without lesions: maximal inhibitory dilution of Propolis and Periogard |
spellingShingle |
Candida sp in the oral cavity with and without lesions: maximal inhibitory dilution of Propolis and Periogard Azevedo,Rosa Vitória Palamin Oral candidiasis Propolis chlorhexidine yeasts |
title_short |
Candida sp in the oral cavity with and without lesions: maximal inhibitory dilution of Propolis and Periogard |
title_full |
Candida sp in the oral cavity with and without lesions: maximal inhibitory dilution of Propolis and Periogard |
title_fullStr |
Candida sp in the oral cavity with and without lesions: maximal inhibitory dilution of Propolis and Periogard |
title_full_unstemmed |
Candida sp in the oral cavity with and without lesions: maximal inhibitory dilution of Propolis and Periogard |
title_sort |
Candida sp in the oral cavity with and without lesions: maximal inhibitory dilution of Propolis and Periogard |
author |
Azevedo,Rosa Vitória Palamin |
author_facet |
Azevedo,Rosa Vitória Palamin Komesu,Marilena Chinalli Candido,Regina Celia Salvetti,Cristiane Rezende,Fausto Hanaoka Caetano |
author_role |
author |
author2 |
Komesu,Marilena Chinalli Candido,Regina Celia Salvetti,Cristiane Rezende,Fausto Hanaoka Caetano |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Azevedo,Rosa Vitória Palamin Komesu,Marilena Chinalli Candido,Regina Celia Salvetti,Cristiane Rezende,Fausto Hanaoka Caetano |
dc.subject.por.fl_str_mv |
Oral candidiasis Propolis chlorhexidine yeasts |
topic |
Oral candidiasis Propolis chlorhexidine yeasts |
description |
Fifty individuals of both sexes aged on average 45.2 years were evaluated at the Semiology Clinic of FORP-USP in order to isolate and identify yeasts from the oral cavity, with and without lesions, and to determine the maximal inhibitory dilution (MID) of the commercial products Propolis (Apis-Flora) and Periogard (Colgate) against the strains isolated. Yeasts of the genus Candida were detected in the saliva of 9/19 (47.4%) individuals with a clinically healthy mouth, 18/22 (81.8%) of individuals with oral lesions, and in 4/9 (44.4%) of patients with deviation from normality, and were detected in 19/22 (86.4%) of the lesions. In the group with oral candidiasis, we isolated in tongue and lesion, respectively for each specie: C.tropicalis (8% and 10.7%), C.glabrata (4% and 3.6%) and C.parapsilosis (2% and 3.6%), in addition to C.albicans (71.4% and 67.8%) as the only species and the prevalent. The total cfu counts/ml saliva showed a higher mean value in the group with oral candidiasis (171.5% x 10(3)) than in the control group (72.6 x 10(3)) or the group with abnormalities (8.3 x 10(3)). Most of the test strains 67/70 (95.71%) were sensitive to the antiseptics, with Propolis presenting a MID of 1:20 for 54/70/77.1%), and Periogard a MID of 1:160 for 42/70 (60%) strains from healthy sites, results similar to those obtained with strains from oral lesions. Different results were mainly observed among different species. The results indicate the possibility of using the antiseptics Propolis and Periogard (chlorhexidine) for the prevention and treatment of oral candidiasis. |
publishDate |
1999 |
dc.date.none.fl_str_mv |
1999-12-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0001-37141999000400008 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0001-37141999000400008 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/S0001-37141999000400008 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Sociedade Brasileira de Microbiologia |
publisher.none.fl_str_mv |
Sociedade Brasileira de Microbiologia |
dc.source.none.fl_str_mv |
Revista de Microbiologia v.30 n.4 1999 reponame:Revista de Microbiologia instname:Sociedade Brasileira de Microbiologia (SBM) instacron:SBM |
instname_str |
Sociedade Brasileira de Microbiologia (SBM) |
instacron_str |
SBM |
institution |
SBM |
reponame_str |
Revista de Microbiologia |
collection |
Revista de Microbiologia |
repository.name.fl_str_mv |
Revista de Microbiologia - Sociedade Brasileira de Microbiologia (SBM) |
repository.mail.fl_str_mv |
bjm@sbmicrobiologia.org.br||revmicro@icb.usp.br |
_version_ |
1754821030228000768 |